Finished
Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
NCT05416034 · MarsiBionics · Updated 13 June 2022
- What is being tested
- Use of the ATLAS 2025 exoskeleton at home
- For
- Spinal Muscular Atrophy Type II
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 4 years to 9 years. About 3 people. The full rules are on the registry page.
- Where
- Spain
- When
- Starts or started 1 Dec 2017, ends 31 Aug 2018. Registered 13 June 2022.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the impact of the use of a pediatric exoskeleton on the quality of life of children, specifically in the psychological and care dimensions. Other objectives are to evaluate changes at the physical and functional level.
Sites
- Hospital Ramón y CajalMadrid, Spain